Which laboratory finding most strongly suggests a cholestatic process?

Which laboratory finding most strongly suggests a cholestatic process?

• A. Elevated bilirubin with normal alkaline phosphatase
• B. Elevated alkaline phosphatase with positive antimitochondrial antibodies
• C. Normal liver enzymes
• D. Low alkaline phosphatase

Answer: (B)

Cholestasis occurs when bile formation or flow is impaired, so the liver injury pattern tends to elevate enzymes produced by bile ducts, especially alkaline phosphatase. When alkaline phosphatase is elevated and antimitochondrial antibodies are present, it points specifically to an autoimmune cholangiopathy, most classically primary biliary cholangitis, a quintessential cholestatic liver disease. The antibodies indicate an autoimmune process affecting the smaller intrahepatic bile ducts, while the ALP elevation reflects bile duct injury or obstruction. In contrast, elevated bilirubin with a normal alkaline phosphatase is not characteristic of cholestasis and can reflect other processes, such as mild hyperbilirubinemia without bile flow compromise, or hepatocellular injury where AST/ALT would be more prominently raised. Normal liver enzymes argue against active liver injury, and low alkaline phosphatase does not fit a cholestatic pattern.

Cholestasis occurs when bile formation or flow is impaired, so the liver injury pattern tends to elevate enzymes produced by bile ducts, especially alkaline phosphatase. When alkaline phosphatase is elevated and antimitochondrial antibodies are present, it points specifically to an autoimmune cholangiopathy, most classically primary biliary cholangitis, a quintessential cholestatic liver disease. The antibodies indicate an autoimmune process affecting the smaller intrahepatic bile ducts, while the ALP elevation reflects bile duct injury or obstruction.

In contrast, elevated bilirubin with a normal alkaline phosphatase is not characteristic of cholestasis and can reflect other processes, such as mild hyperbilirubinemia without bile flow compromise, or hepatocellular injury where AST/ALT would be more prominently raised. Normal liver enzymes argue against active liver injury, and low alkaline phosphatase does not fit a cholestatic pattern.